NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Greg Kunst, president and CEO of Aurion Biotech, discusses the potential of the company’s technology to work toward cures for corneal endothelial disease.
Uncategorized
VIDEO: Aurion Biotech discusses keys to treating patients with corneal endothelial disease